This investigation analyzed changes in CEA/CA 19-9 expression profiles within 2,596 CRC patients, with significant associations found between elevated CEA/CA 19-9 expression profiles inside the reference range and recurrence. The gene discussed is CEACAM5; the disease is colorectal carcinoma.